A combination of three different drugs that block the HER-2 receptor, a critical cellular growth signal for some breast cancers, eradicated aggressive breast tumors in mice and could point the way toward developing better treatments in patients, said researchers from the Breast Center at Baylor College of Medicine in a report that appears in the Journal of the National Cancer Institute.
A new test may be able to identify women at risk for breast cancer long before a lump appears on a mammogram, according to the makers of the new test, called Halo? Breast Pap Test System.
Nearly one-fifth of breast tumors have extra copies of the gene encoding one form of the estrogen receptor ESR1, suggests a study published online this week in Nature Genetics.
Only one per cent of women know that older women – those 80 or older – have the greatest risk of developing breast cancer according to new research published.
Step-Up students from Corpus Christi College and Orangefield High School served up a feast at the Jordanstown campus to raise money for charity.
Hamilton College researchers have identified molecules that have been shown to be effective in the fight against breast cancer.
The use of computer-aided detection (CAD) with computed radiography (CR) is effective in the detection of breast cancer, according to a recent study conducted by radiologists at George Washington University Medical Center in Washington, D.C., and iCAD in Nashua, N.H.
Roche announced that the European Commission has approved the use of Herceptin in combination with an aromatase inhibitor for the treatment of postmenopausal patients with HER2 and hormone receptor co-positive metastatic breast cancer.
Hamilton College researchers have identified molecules that have been shown to be effective in the fight against breast cancer. The Hamilton researchers used state-of-the-art computational techniques in a novel way to design molecules that they predicted would be effective lead compounds for breast cancer research.
A new study, published in the Online Open Access journal Breast Cancer Research, reveals two distinct patterns in the recent breast cancer rates in U.S. women: a downturn in the incidence rates in almost all age groups above 45 years beginning in 1998/1999, consistent with a levelling off of mammography utilization, and a sharp fall in the rates between 2002 and 2003 in the age groups 50-69 years, likely reflecting the early benefit of the reduced use of HRT.